Ocugen (OCGN) Revenue (2014 - 2026)
Ocugen (OCGN) reported Revenue of $1.5 million for Q1 2026, up 3.51% on a YoY basis from $1.5 million in Q1 2025, and up 894.3% quarter-over-quarter from -$193000.0 in Q4 2025.
Ocugen (OCGN) Revenue (2014 - 2026) Analysis & Trends
Ocugen has reported Revenue for 7 years, with the latest figure at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 3.51% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 1.26% YoY), and the FY2025 full-year result was $4.4 million, up 8.83% from the prior year.
- Revenue for Q1 2026 stood at $1.5 million, up from -$193000.0 in the prior quarter.
- The five-year high for Revenue was $3.7 million in Q3 2023, with the low at -$193000.0 in Q4 2025.
- Historically, Revenue has averaged $1.1 million across 5 years, with a median of $1.0 million in 2024.
- Annual changes were most pronounced in 2023 — Revenue surged 693.78% — and 2025, when it plunged 125.26%.
- Ocugen's Revenue stood at $879000.0 in 2022, then soared by 60.3% to $1.4 million in 2023, then plunged by 45.78% to $764000.0 in 2024, then sank by 125.26% to -$193000.0 in 2025, then jumped by 894.3% to $1.5 million in 2026.
- The last three Revenue figures came in at $1.5 million (Q1 2026), -$193000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | -193,000.00 |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 764,000.00 |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 1.41 Mn |
| Sep 30, 2023 | 3.70 Mn |
| Jun 30, 2023 | 485,000.00 |
| Mar 31, 2023 | 443,000.00 |
| Dec 31, 2022 | 879,000.00 |
| Sep 30, 2022 | 466,000.00 |
| Jun 30, 2022 | 643,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Jun 30, 2020 | 43,000.00 |
| Sep 30, 2014 | 650.00 Mn |